Peptide-based treatment of sepsis (Q37849200)

24 August 2017

1 reference

title

Peptide-based treatment of sepsis (English)

1 reference

24 August 2017

0 references

2

Jörg Andrä

0 references

Klaus Brandenburg

series ordinal

1

object named as

Klaus Brandenburg

1 reference

24 August 2017

Patrick Garidel

3

1 reference

PubMed ID

21369803

24 August 2017

Thomas Gutsmann

series ordinal

4

1 reference

PubMed ID

21369803

24 August 2017

language of work or name

English

0 references

publication date

3 March 2011

1 reference

Applied Microbiology and Biotechnology

24 August 2017

1 reference

24 August 2017

90

1 reference

24 August 2017

3

1 reference

24 August 2017

799-808

1 reference

https://scigraph.springernature.com/pub.10.1007/s00253-011-3185-7

24 August 2017

0 references

cites work

NK-lysin, structure and function of a novel effector molecule of porcine T and NK cells

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3185-7

Biophysical characterization of the interaction of Limulus polyphemus endotoxin neutralizing protein with lipopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3185-7

Biophysical characterization of endotoxin inactivation by NK-2, an antimicrobial peptide derived from mammalian NK-lysin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3185-7

Cyclic antimicrobial peptides based on Limulus anti-lipopolysaccharide factor for neutralization of lipopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3185-7

Enhancement of endotoxin neutralization by coupling of a C12-alkyl chain to a lactoferricin-derived peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3185-7

Mechanism of interaction of optimized Limulus-derived cyclic peptides with endotoxins: thermodynamic, biophysical and microbiological analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3185-7

Rationale for the design of shortened derivatives of the NK-lysin-derived antimicrobial peptide NK-2 with improved activity against Gram-negative pathogens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3185-7

Association between protective efficacy of anti-lipopolysaccharide (LPS) antibodies and suppression of LPS-induced tumor necrosis factor alpha and interleukin 6. Comparison of O side chain-specific antibodies with core LPS antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3185-7

Biophysical characterization of lipopolysaccharide and lipid A inactivation by lactoferrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3185-7

Temperature dependence of the binding of endotoxins to the polycationic peptides polymyxin B and its nonapeptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3185-7

Molecular basis for endotoxin neutralization by amphipathic peptides derived from the alpha-helical cationic core-region of NK-lysin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3185-7

Biophysical analysis of the interaction of granulysin-derived peptides with enterobacterial endotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3185-7

Antimicrobial and chemoattractant activity, lipopolysaccharide neutralization, cytotoxicity, and inhibition by serum of analogs of human cathelicidin LL-37.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3185-7

hCAP-18, a cathelin/pro-bactenecin-like protein of human neutrophil specific granules

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3185-7

Clinical effects of polymyxin B-immobilized fiber column in septic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3185-7

Synthetic endotoxin-binding peptides block endotoxin-triggered TNF-alpha production by macrophages in vitro and in vivo and prevent endotoxin-mediated toxic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3185-7

Molecular cloning and characterization of equine NK-lysin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3185-7

Affinities of different proteins and peptides for lipopolysaccharide as determined by biosensor technology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3185-7

Granulysin, a cytolytic molecule, is also a chemoattractant and proinflammatory activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3185-7

Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3185-7

Characterization of bovine homologues of granulysin and NK-lysin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3185-7

Toxicity of polymyxins: a systematic review of the evidence from old and recent studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3185-7

Biochemical and antibacterial analysis of human wound and blister fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3185-7

Structural prerequisites for endotoxic activity in the Limulus test as compared to cytokine production in mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3185-7

New antiseptic peptides to protect against endotoxin-mediated shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3185-7

Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3185-7

Evidence of immunostimulating lipoprotein existing in the natural lipoteichoic acid fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3185-7

Structure-microbicidal activity relationship of synthetic fragments derived from the antibacterial alpha-helix of human lactoferrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3185-7

Bacterial strategies for overcoming host innate and adaptive immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3185-7

Thermodynamic analysis of the lipopolysaccharide-dependent resistance of gram-negative bacteria against polymyxin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3185-7

Structural origin of endotoxin neutralization and antimicrobial activity of a lactoferrin-based peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3185-7

Physicochemical and biological characterization of anti-endotoxin peptides and their influence on lipid properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3185-7

Complementary DNA sequence of rabbit CAP18--a unique lipopolysaccharide binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3185-7

Reduction of the severe sepsis or septic shock associated mortality by reinforcement of the recommendations bundle: a multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3185-7

Defensins of vertebrate animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3185-7

Ancient weapons: NK-lysin, is a mammalian homolog to pore-forming peptides of a protozoan parasite

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3185-7

Saposin fold revealed by the NMR structure of NK-lysin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3185-7

The human cationic antimicrobial protein (hCAP-18) is expressed in the epithelium of human epididymis, is present in seminal plasma at high concentrations, and is attached to spermatozoa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3185-7

Colistin and polymyxin B in critical care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3185-7

The novel beta-defensin DEFB123 prevents lipopolysaccharide-mediated effects in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3185-7

Clinical gram-positive sepsis: does it fundamentally differ from gram-negative bacterial sepsis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3185-7

Shrimp (Penaeus monodon) anti-lipopolysaccharide factor reduces the lethality of Pseudomonas aeruginosa sepsis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3185-7

A novel tetrabranched antimicrobial peptide that neutralizes bacterial lipopolysaccharide and prevents septic shock in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3185-7

Anti-tumor necrosis factor therapy in sepsis: update on clinical trials and lessons learned

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3185-7

A synthetic cyclic peptide derived from Limulus anti-lipopolysaccharide factor neutralizes endotoxin in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3185-7

Cutting edge: cationic antimicrobial peptides block the binding of lipopolysaccharide (LPS) to LPS binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3185-7

Phase 2 trial of eritoran tetrasodium (E5564), a toll-like receptor 4 antagonist, in patients with severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3185-7

Bactericidal activity of mammalian cathelicidin-derived peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3185-7

Structural studies of a peptide with immune modulating and direct antimicrobial activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3185-7

Synergistic effect of muramyldipeptide with lipopolysaccharide or lipoteichoic acid to induce inflammatory cytokines in human monocytic cells in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3185-7

Cathelicidins: a novel protein family with a common proregion and a variable C‐terminal antimicrobial domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3185-7

10.1007/S00253-011-3185-7

21 January 2018

Identifiers

DOI

1 reference

24 August 2017

1 reference

PubMed ID

21369803